Gaucher disease

ICD-10: 5C56.0MeSH: D005776ORPHA: 683662 Treatments Available

Overview

Gaucher disease is a lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, leading to deficient glucocerebrosidase activity and accumulation of glucocerebroside in macrophages. Common features include hepatosplenomegaly, anemia, thrombocytopenia, bone pain, and skeletal disease; neuronopathic forms can cause neurologic impairment. It is rare, with the non-neuronopathic type 1 form being the most common globally, and several enzyme replacement and substrate reduction therapies are documented.

Available Treatments (2)

DrugFormStatusCountriesLead Time
eliglustat
Orphan
Oral capsule, 84mgFDA Approved, EMA Approved710d
Imiglucerase
Orphan Cold Chain
IV infusion, 200 units/vial, 400 units/vialFDA Approved614d

Classification & Codes

ICD-10 Code

5C56.0

MeSH Code

D005776

Orphanet Code

ORPHA:68366
Gaucher disease
ICD-105C56.0
MeSHD005776
OrphanetORPHA:68366
Treatments2 drug(s)
Statuspublished
Factual Authority
Last Updated7/24/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO